Grant: Master's Award: Canada Graduate Scholarships
McMaster University
$17,500.00
Understanding the Role of Immunoglobulin A in Respiratory Virus Infection
FY 2022-23
Summary
Effective immunity against respiratory viruses is facilitated by mucosal immunity, which relies, in part, on the action of immunoglobulin A (IgA). Little is known about the mechanisms through which IgA mediates protection against respiratory virus infection. Indeed, the effect of subclasses (IgA1 and IgA2), relative contributions of neutralization vs. Fc-mediated effector functions, and antibody structures (monomeric, dimeric, secretory) on protection against SARS-CoV-2 and influenza A virus (IAV) infections has so far been elusive. The overarching aim of this research is to systematically define how the aforementioned features of IgA impact its ability to protect against IAV and SARS-CoV-2 infection. We hypothesize that the interaction between IgA and the Fc alpha receptor plays a vital role in the maintenance of immunity against these respiratory viruses.
The first aim of research is to characterize how IgA subclass (IgA1 vs. IgA2) affects binding and neutralization properties. A variety of anti-hemagglutinin (HA) monoclonal antibodies against IAV, and anti-S protein monoclonal antibodies against SARS-CoV-2 will be cloned, expressed, and purified. Each will be produced in monomeric, dimeric, and secretory forms, and binding kinetics will be measured by ELISA and biolayer interferometry assays. Neutralization assays will also be performed using live viruses.
The second aim of research is to determine the impact of IgA subclass and structure on the ability to activate neutrophils via the Fc alpha receptor. Virus-IgA complexes will be incubated with neutrophils to measure their activation.
Finally, the third aim of research is to determine how IgA subclass and structure influence efficacy in vivo using transgenic mice expressing the human Fc alpha receptor.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486341
Name
Fletcher Charlotte E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Understanding the Role of Immunoglobulin A in Respiratory Virus Infection
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antibody; Immunity; Immunoglobulin A; Influenza A Virus; Monoclonal Antibodies; Mucosal Immunity; Respiratory Viruses; Sars-Cov-2 Virus; Vaccines
Abstract
Effective immunity against respiratory viruses is facilitated by mucosal immunity, which relies, in part, on the action of immunoglobulin A (IgA). Little is known about the mechanisms through which IgA mediates protection against respiratory virus infection. Indeed, the effect of subclasses (IgA1 and IgA2), relative contributions of neutralization vs. Fc-mediated effector functions, and antibody structures (monomeric, dimeric, secretory) on protection against SARS-CoV-2 and influenza A virus (IAV) infections has so far been elusive. The overarching aim of this research is to systematically define how the aforementioned features of IgA impact its ability to protect against IAV and SARS-CoV-2 infection. We hypothesize that the interaction between IgA and the Fc alpha receptor plays a vital role in the maintenance of immunity against these respiratory viruses.
The first aim of research is to characterize how IgA subclass (IgA1 vs. IgA2) affects binding and neutralization properties. A variety of anti-hemagglutinin (HA) monoclonal antibodies against IAV, and anti-S protein monoclonal antibodies against SARS-CoV-2 will be cloned, expressed, and purified. Each will be produced in monomeric, dimeric, and secretory forms, and binding kinetics will be measured by ELISA and biolayer interferometry assays. Neutralization assays will also be performed using live viruses.
The second aim of research is to determine the impact of IgA subclass and structure on the ability to activate neutrophils via the Fc alpha receptor. Virus-IgA complexes will be incubated with neutrophils to measure their activation.
Finally, the third aim of research is to determine how IgA subclass and structure influence efficacy in vivo using transgenic mice expressing the human Fc alpha receptor.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fletcher, Charlotte E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~